Marine pharmacology in 2012–2013: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral …

AMS Mayer, AD Rodríguez, O Taglialatela-Scafati… - Marine drugs, 2017 - mdpi.com
The peer-reviewed marine pharmacology literature from 2012 to 2013 was systematically
reviewed, consistent with the 1998–2011 reviews of this series. Marine pharmacology …

Marine pharmacology in 2014–2015: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, antiviral, and …

AMS Mayer, AJ Guerrero, AD Rodríguez… - Marine Drugs, 2019 - mdpi.com
The systematic review of the marine pharmacology literature from 2014 to 2015 was
completed in a manner consistent with the 1998–2013 reviews of this series. Research in …

Marine pharmacology in 2016–2017: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis and antiviral …

AMS Mayer, AJ Guerrero, AD Rodríguez… - Marine drugs, 2021 - mdpi.com
The review of the 2016–2017 marine pharmacology literature was prepared in a manner
similar as the 10 prior reviews of this series. Preclinical marine pharmacology research …

Marine pharmacology in 2009–2011: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral …

AMS Mayer, AD Rodríguez, O Taglialatela-Scafati… - Marine drugs, 2013 - mdpi.com
The peer-reviewed marine pharmacology literature from 2009 to 2011 is presented in this
review, following the format used in the 1998–2008 reviews of this series. The …

Marine pharmacology in 2018: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis and antiviral activities; …

AMS Mayer, ML Pierce, K Howe, AD Rodríguez… - Pharmacological …, 2022 - Elsevier
The 2018 marine pharmacology literature review represents a continuation of the previous
11 reviews of a series initiated in 1998. Preclinical marine pharmacology research during …

Marine pharmacology in 2007–8: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and …

AMS Mayer, AD Rodríguez, RGS Berlinck… - … and Physiology Part C …, 2011 - Elsevier
The peer-reviewed marine pharmacology literature in 2007–8 is covered in this review,
which follows a similar format to the previous 1998–2006 reviews of this series. The …

[图书][B] Marine Pharmacognosy: Trends and Applications

SK Kim - 2012 - books.google.com
Diverse and abundant, marine-derived bioactive compounds offer a plethora of
pharmacologically active agents with the potential to produce valuable therapeutic entities …

Marine pharmacology in 2005–6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal …

AMS Mayer, AD Rodríguez, RGS Berlinck… - … et Biophysica Acta (BBA …, 2009 - Elsevier
BACKGROUND: The review presents the 2005–2006 peer-reviewed marine pharmacology
literature, and follows a similar format to the authors' 1998–2004 reviews. The preclinical …

Marine pharmacology in 2000: marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and …

AMS Mayer, MT Hamann - Marine Biotechnology, 2004 - Springer
During 2000 research on the pharmacology of marine chemicals involved investigators from
Australia, Brazil, Canada, Egypt, France, Germany, India, Indonesia, Israel, Italy, Japan, the …

Marine natural products in clinical use

N Haque, S Parveen, T Tang, J Wei, Z Huang - Marine drugs, 2022 - mdpi.com
Marine natural products are potent and promising sources of drugs among other natural
products of plant, animal, and microbial origin. To date, 20 drugs from marine sources are in …